Medistep Healthcare Ltd vs Samsrita Labs Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Oct 25, 2026

Key Highlights

The Latest Trading Price of Medistep Healthcare Ltd is ₹ 21.4 as of 19 Oct 15:30 . The P/E Ratio of Medistep Healthcare Ltd changed from 0 on March 2021 to 0 on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe P/E Ratio of Samsrita Labs Ltd changed from 28.5 on March 2022 to 0 on March 2026 . This represents a CAGR of -100.00% over 5 years The Market Cap of Medistep Healthcare Ltd changed from ₹ 0 crore on March 2021 to ₹ 0 crore on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe Market Cap of Samsrita Labs Ltd changed from ₹ 64.64 crore on March 2021 to ₹ 36.08 crore on March 2026 . This represents a CAGR of -9.26% over 6 years The revenue of Medistep Healthcare Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of Samsrita Labs Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 revenue of ₹ 0.05 crore. This represent the decline of -100% The ebitda of Medistep Healthcare Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of Samsrita Labs Ltd for the Jun '26 is ₹ -0.31 crore as compare to the Mar '26 ebitda of ₹ -0.12 crore. This represent the growth of 158.33% The net profit of Medistep Healthcare Ltd changed from ₹ 0 crore to ₹ 0 crore over 7 quarters. This represents a CAGR of 0.0% The net profit of Samsrita Labs Ltd changed from ₹ -0.28 crore to ₹ -0.31 crore over 5 quarters. This represents a CAGR of 8.48% The Dividend Payout of Medistep Healthcare Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe Dividend Payout of Samsrita Labs Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 years .

About Medistep Healthcare Ltd

Medistep Healthcare Limited was originally incorporated on June 05, 2023 as a Public Limited Company, pursuant to a Certificate of Incorporation issued by Registrar of Companies, Gujarat.
Thereafter, the Company acquired the business of Proprietorship Concern of one of the Promoter Ms. Prajapati Hetalben Girdharilal viz, M/s MG Pharma through the business transfer agreement dated July 02, 2023.
Subsequently the business of sole proprietorship firm was transferred into Medistep Healthcare Limited as a going concern. Before the incorporation of Medistep Healthcare Limited, M/s MG Pharma was involved in the business of trading of pharmaceutical products, intimate care and hygiene products, surgical products, equipment and Nutraceutical products.
Medistep Healthcare is a Pharmaceutical Company that has carved a niche in the Healthcare Industry in manufacturing Sanitary pads, Energy powder and trading a diverse range of pharmaceutical products.

About Samsrita Labs Ltd

Samsrita Labs Limited was initially established as 'Dr Habeebullah Life Sciences Limited' on January 25, 1996.
The name of the Company was changed from Dr Habeebullah Life Sciences Limited to Samsrita Labs Limited on October 13, 2022.
Company, initially focused on three different verticals called, Stem cell related Hospitals, Molecular Diagnostics and R&D in New Drug Discovery but due to other reasons, aimed to shifting into Bio-pharma activities like Trading, Exports & Imports, manufacturing of Bulk drugs, APIs, Specialty drugs, R&D etc through joint ventures or associations or mergers or by its own.
The Company is engaged into the business of research & experimental development on natural sciences and engineering, including bio pharma and hospital services also. In 2017, the Company changed its Main Objects clauses by venturing into the business of Bio-Pharma and also entered the following areas like New Drug Discovery including New Molecular Entity (NME - Pro Drug); Clinical Research Organization (CRO) related activities; Stem Cell - Lab, Research and Therapy; Research and Development in Bio-technology; Consultancy Division and Pharmacy; Academic Services like Courses / Lectures / Seminars on Biotechnology, Pharma, Stem Cell Research and therapy, Clinical Research and animal studies etc.

FAQs for the comparison of Medistep Healthcare Ltd and Samsrita Labs Ltd

Which company has a larger market capitalization, Medistep Healthcare Ltd or Samsrita Labs Ltd?

Market cap of Medistep Healthcare Ltd is 30 Cr while Market cap of Samsrita Labs Ltd is 30 Cr

What are the key factors driving the stock performance of Medistep Healthcare Ltd and Samsrita Labs Ltd?

The stock performance of Medistep Healthcare Ltd and Samsrita Labs Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Medistep Healthcare Ltd and Samsrita Labs Ltd?

As of October 25, 2026, the Medistep Healthcare Ltd stock price is INR ₹21.4. On the other hand, Samsrita Labs Ltd stock price is INR ₹13.42.

How do dividend payouts of Medistep Healthcare Ltd and Samsrita Labs Ltd compare?

To compare the dividend payouts of Medistep Healthcare Ltd and Samsrita Labs Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.